We have a strong track record advising leading multinationals (particularly tech and life sciences businesses) on M&A, joint ventures, complex carve-outs, technology, licensing, and commercial arrangements.

When the value of an investment hinges on IP, we help companies diligence the scope of protection and assess all types of IP risks, ranging from open source software traps to patent infringement.

Data (including personal data) is often at the heart of the deals we advise on, because it underpins the commercial and innovation strategies of global tech companies and digital transformers alike. Whether companies are acquiring new capabilities or collaborating, we help them acquire rights in data (both from an IP and regulatory perspective) and we know what’s “market” in data licensing to secure the value of investments or partnerships.

Data security and privacy issues are now front and centre in M&A negotiations to ensure that buyers do not introduce vulnerabilities into their own environment through investments. Leveraging our experience advising on one of the most high-profile global data incidents resulting from an acquisition, we help acquirers conduct robust due diligence and calibrate data and cyber risk at all stages of the transaction. Our global team knows how to drive value from data while managing its risks.